US Stock MarketDetailed Quotes

AGIO Agios Pharmaceuticals

Watchlist

33.220
-0.080-0.24%

Close Feb 14 16:00 ET

33.220
0.0000.00%

Post 20:01 ET

1.90BMarket Cap2.85P/E (TTM)

Agios Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Agios Pharmaceuticals Q4 2024 Earnings Date

Currency：USDFeb 13, 2025

	Estimate (YoY)	Actual (YoY)	Vs Estimate (% Chg)
Revenue	9.35M	10.73M	+1.38M
Beat Est.	+31.60%	+51.06%	+14.79%
EPS	-1.69	-1.74	-0.05
Miss Est.	+1.72%	-1.16%	-2.93%

Analyst Rating

Strong Buy

Feb 17, 2025

Agios Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 6 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q2	-- / 10.873M	--
--	2025/Q1	-- / 10.158M	--
Feb 13, 2025	2024/Q4	10.730M / 9.347M	--
Oct 31, 2024	2024/Q3	8.964M / 9.502M	--
Aug 1, 2024	2024/Q2	8.615M / 9.307M	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q2-- / 10.873M--

--2025/Q1-- / 10.158M--

Feb 13, 20252024/Q410.730M / 9.347M--

Oct 31, 20242024/Q38.964M / 9.502M--

Aug 1, 20242024/Q28.615M / 9.307M--

Unlock Free Earnings Estimates

Open Account

Agios Pharmaceuticals Earnings Reports

Agios Pharmaceuticals | 10-K: FY2024 Annual Report

Feb 13 09:29 ET

Agios Pharmaceuticals | 8-K: Agios Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights

Feb 13 06:34 ET

Agios Pharmaceuticals | 10-Q: Q3 2024 Earnings Report

Oct 31, 2024 09:26 ET

Agios Pharmaceuticals | 8-K: Agios Reports Business Highlights and Third Quarter 2024 Financial Results

Oct 31, 2024 07:00 ET